Connection

Stephanie Pfaender to Antiviral Agents

This is a "connection" page, showing publications Stephanie Pfaender has written about Antiviral Agents.
Connection Strength

0.337
  1. Antiviral Effect of Budesonide against SARS-CoV-2. Viruses. 2021 07 20; 13(7).
    View in: PubMed
    Score: 0.088
  2. Research Models and Tools for the Identification of Antivirals and Therapeutics against Zika Virus Infection. Viruses. 2018 10 30; 10(11).
    View in: PubMed
    Score: 0.073
  3. The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor. Antimicrob Agents Chemother. 2018 11; 62(11).
    View in: PubMed
    Score: 0.073
  4. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models. Virus Res. 2021 09; 302:198469.
    View in: PubMed
    Score: 0.022
  5. Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2. J Hosp Infect. 2021 Jun; 112:27-30.
    View in: PubMed
    Score: 0.022
  6. Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476. J Hosp Infect. 2021 May; 111:180-183.
    View in: PubMed
    Score: 0.021
  7. Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2020 09 14; 222(8):1289-1292.
    View in: PubMed
    Score: 0.021
  8. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry. Antiviral Res. 2017 11; 147:19-28.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.